Atlas Trials

Phase 1 Single Ascending Dose Study

Clinical trial NCT06934941 · RECRUITING

Trial details

NCT number
NCT06934941
Sponsor
Neuramedy Co. Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2024-11-25
Primary completion
2025-10-30
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.